SCADDEN DAVID 1707715 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Scadden David | DIRECTOR | acq | 4975.0 | 41.13 | 0.9 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 12095.0 | 55.58 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Scadden David | DIRECTOR | acq | 25000.0 | 100.0 | 3.62 | 9.55 | Direct | Stock Option (Right To Buy) | EDITAS MEDICINE, INC. | code A | 25000.0 | 69.0 (EDIT) |
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Scadden David | DIRECTOR | acq | 3388.0 | 100.0 | 0.61 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 3388.0 | 55.58 (AGIO) |
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Scadden David | DIRECTOR | acq | 18958.0 | 100.0 | 3.41 | 26.56 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 18958.0 | 55.58 (AGIO) |
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Scadden David | DIRECTOR | dsp | 4975.0 | 100.0 | 0.9 | 0.0 | Direct | Restricted Stock Unit | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.58 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)